Aspirin for Primary Prevention
Sign up for free
Listen to this episode and many more. Enjoy the best podcasts on Spreaker!
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
An update on the use of aspirin in primary prevention of cardiovascular disease. We will review three large trials published in 2018, the ARRIVE Trial, ASCEND Trial, and ASPREE Trial...
show moreWe will review three large trials published in 2018, the ARRIVE Trial, ASCEND Trial, and ASPREE Trial that compared risks vs. benefits of aspirin in a variety of different primary prevention populations. We will also explore new guideline recommendations as a result of this new evidence. Finally, I’ll try and summarize the impact this will have on practice and how I personally am changing the way I’m managing aspirin use.
Information
Author | Pharmacy Society of Wisconsin |
Organization | Pharmacy Society of Wisconsin |
Website | - |
Tags |
-
|
Copyright 2024 - Spreaker Inc. an iHeartMedia Company